Live feed06:34:00·20dPRReleasevia QuantisnowCereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure HydrocephalusByQuantisnow·Wall Street's wire, on your screen.PIPR· Piper Sandler CompaniesFinance